Hospital of the University ofPennsylvania
Philadelphia, Pennsylvania PA19104
92 studies enrolling now · 707 studies all time
What they study most
AAA - Abdominal Aortic Aneurysm, AL Amyloidosis, AML, AML With Mutated NPM1, ARDS, ARDS (Acute Respiratory Distress Syndrome), Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder), Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder), Abdominal Aortic Aneurysms, Abdominal Aortic Aneurysms (AAA), Abdominal Cramping
Studies at this site
- DE-RESTRICT: Deimplementing Activity Restriction for Preterm Birth Prevention — Recruiting now
- Assessment of CCM in HF With Higher Ejection Fraction — Recruiting now
- Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC) — Recruiting now
- Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen — Recruiting now
- A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome Associated With Intestinal Failure (SBS-IF) — Recruiting now
- Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF) — Recruiting now
- Healing at Home 2.0 - Enhanced Chat Tool for Lowering Postpartum Depression — Recruiting now
- Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors — Recruiting now
- AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy — Recruiting now
- Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01) — Recruiting now
- A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta — Recruiting now
- A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation — Recruiting now
- TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas — Recruiting now
- A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late-Onset Pompe Disease (PROGRESS-GT LOPD) — Recruiting now
- Supraglottic Airway for Resuscitation in Preemies — Recruiting now
- The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs). — Recruiting now
- Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) — Recruiting now
- Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma — Recruiting now
- BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT — Recruiting now
- GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections — Recruiting now
- Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial — Recruiting now
- An Intervention Mapping Approach to Closing the Gap in Maternal OUD and Infant NAS Care (SUPPORT) — Recruiting now
- A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) — Recruiting now
- Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset — Recruiting now
- A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes — Recruiting now
- The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial — Recruiting now
- Allergy Delabeling in Antibiotic Stewardship - Intervention — Recruiting now
- Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS) — Recruiting now
- Patient Navigation to Improve Surgical Access in Primary Hyperparathyroidism — Recruiting now
- Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies — Recruiting now
- The THOR IDE Study — Recruiting now
- Early General Anesthesia to Limit Experiences of Trauma During Cesarean Section-Pilot Study — Recruiting now
- Lung Injury is One of the Primary Causes of Morbidity and Mortality in Critically Ill Patients. These Patients Will be Monitored for: 1) Immune Cell Activation 2) Blood-based Biomarkers. In Vitro Models Derived From These Samples Will be Treated With Novel Agent PIP-2 to Evaluate Its Efficacy. — Recruiting now
- Maintenance Combinatorial Myeloid Immunotherapy for Unresectable Pancreatic Cancer — Recruiting now
- NEPTUNE Match Study — Recruiting now
- ViewFlex X ICE First-in-Human Study — Recruiting now
- CTSN Embolic Protection Trial — Recruiting now
- Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung — Recruiting now
- Nectero EAST System Clinical Study — Recruiting now
- Identification of Breast Cancer in Breath Samples Using Trained Detection Dogs — Recruiting now
- Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT) — Recruiting now
- Uterine Preservation in the Management of Placenta Accreta Spectrum Disorders — Recruiting now
- Anticoagulation in ICH Survivors for Stroke Prevention and Recovery — Recruiting now
- Window Study of Intratumoral Mitazalimab in Breast Cancer (WINIT-BC) — Recruiting now
- Videos to Aid Decision Making for Fibroid Treatment — Recruiting now
- Prevail Global Study — Recruiting now
- Randomized Assessment of TcMS for VT Storm — Recruiting now
- CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL) — Recruiting now
- Valved Graft PMCF Study — Recruiting now
- Azithromycin Prophylaxis for PRElabor CEsarean DElivery Trial — Recruiting now